Grand Challenges in Global Health has awarded $30 million for the creation of diagnostic tools for use in the developing world. These devices will be designed to assess illnesses and health risks while patients are still at a health care setting. Developing lower cost, easier to use diagnostics will help increase access to health care in resource-poor areas.

Grand Challenges in Global Health has awarded $30 million for the creation of diagnostic tools for use in the developing world. These devices will be designed to assess illnesses and health risks while patients are still at a health care setting. Developing lower cost, easier to use diagnostics will help increase access to health care in resource-poor areas.

Grand Challenges in Global Health - Point-of-Care Diagnostics

Point-of-Care Diagnostics

Donald Chickering and a team at Seventh Sense Biosystems in the U.S. are developing a one-step blood collection using microneedles and a vacuum to capture a blood sample for analysis.

A Universal One-Step Device to Safely and Painlessly Collect Blood

Investing in New Diagnostics for the Developing World

Grand Challenges

Photo Galleries

Photo Gallery

Robert (Bruce) Cary of Mesa Tech International, Inc. in the U.S. is creating a nucleic acid purification system to provide purified patient samples within minutes without user intervention, instrumentation, electricity or costly materials.

A Disposable Sub-system for Nucleic Acid Sample Preparation Without Instrumentation or User Intervention

Sample Preparation Without Instrumentation or User Intervention

David Beebe and researchers at the University of Wisconsin in the U.S. are developing a sample purification system that uses a wax or oil barrier to filter and concentrate biomarkers from a patient sample. This system will be adaptable to a variety of sample collection and detection components.

Microfluidic Immiscible Phase Barrier: Simplified Sample Preparation for Point-of-Care Diagnostics in the Developing World

A Sample Purification System Using A Wax or Oil Barrier

Ross Durland and colleagues at AM Biotechnologies, LLC in the U.S. are creating modified nucleic acids called X-aptamers that can detect and quantify protein biomarkers in a patient sample while remaining stable at high temperature and humidity.